Envestnet Asset Management Inc Biond Vax Pharmaceuticals Ltd. Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$0.96 - $1.26 $80,838 - $106,100
-84,207 Reduced 51.53%
79,216 $58,000
Q2 2022

Aug 03, 2022
BUY
$1.16 - $1.88 $131,564 - $213,225
113,418 Added 226.81%
163,423 $191,000
Q4 2021

Feb 04, 2022
BUY
$1.48 - $2.92 $74,007 - $146,014
50,005 New
50,005 $118,000

About BiondVax Pharmaceuticals Ltd.

BVXV Quotes by TradingView
  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email